CYCCP

Q: What is the price of Cyclacel Pharmaceuticals (CYCCP) today?

The price of Cyclacel Pharmaceuticals (CYCCP) today is $ 0.00, with return of 0% compared to the last year. The price of Cyclacel Pharmaceuticals (CYCCP) started the year trading around $ 0.56 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Cyclacel Pharmaceuticals (CYCCP) and international markets.

Q: When does Cyclacel Pharmaceuticals (CYCCP) pay dividends?

Cyclacel Pharmaceuticals (CYCCP) distributed dividends in the last year,in the months of May, August and November totaling $ 0.45. The Dividend Yield for the last 12 months is 33.29%.

Q: Is Cyclacel Pharmaceuticals (CYCCP) worth it?

Currently, Cyclacel Pharmaceuticals (CYCCP) is priced at $ 0.00, with a P/E of -8.63%, representando um desvio de -863% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.45 in dividends, resulting in a Dividend Yield of 33.29%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Cyclacel Pharmaceuticals (CYCCP) stock?

Investing in stocks of Cyclacel Pharmaceuticals (CYCCP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Cyclacel Pharmaceuticals (CYCCP) yield today?

The yield of Cyclacel Pharmaceuticals (CYCCP) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.45 in dividends, a Dividend Yield of 33.29%.If you wanted to buy 100 stocks of Cyclacel Pharmaceuticals (CYCCP) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Cyclacel Pharmaceuticals Inc.

Price

$ -

return (12m)

0.00%

p/e

-8.63

p/bv

3.14

DIVIDEND YIELD

33.29%

price CYCCP

CYCCP

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of CYCCP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CYCCP

review the fundamentals of Cyclacel Pharmaceuticals shares

P/E

-8.63

Sector: -3.40 Industry: -3.40

P/SALES RATIO (PSR)

Sector: -3.36 Industry: -3.36

P/BV

3.14

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

33.29%

Sector: - Industry: -

ROA

-30.00%

Sector: -62.78% Industry: -62.78%

ROE

-36.36%

Sector: -68.26% Industry: -68.26%

ROIC

Sector: -1,140.39% Industry: -1,140.39%

NET MARGIN

0.00%

Sector: -41.80% Industry: -41.80%

GROSS MARGIN

0.00%

Sector: 39.33% Industry: 39.33%

OPERATING MARGIN

0.00%

Sector: -41.58% Industry: -41.58%

P/EBITDA

-8.63

Sector: -3.48 Industry: -3.48

P/EBIT

-8.63

Sector: -3.60 Industry: -3.60

P/ASSET

2.59

Sector: 1.42 Industry: 1.42

BVPS

2.30

Sector: 1.79 Industry: 1.79

EPS

-0.84

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.83

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals CYCCP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.42	0.00	0.00%	2.51%	$ 487.73 B	27.26%
PFE	14.23	1.50	10.56%	6.95%	$ 139.89 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.73	7.92	57.70%	3.54%	$ 211.67 B	32.78%
MRK	12.83	0.00	0.00%	3.31%	$ 244.20 B	29.63%
AZN	30.03	6.14	20.45%	1.72%	$ 282.28 B	16.17%
BMY	15.59	5.06	32.47%	5.36%	$ 94.17 B	12.57%
GILD	19.41	7.34	37.80%	2.48%	$ 157.41 B	27.88%
ZTS	20.40	10.02	49.11%	1.58%	$ 54.07 B	28.21%
HALO	13.82	16.33	118.17%	0.00%	$ 8.23 B	47.91%
REGN	17.17	2.54	14.79%	0.35%	$ 78.61 B	32.13%
AMGN	25.92	18.88	72.82%	2.78%	$ 181.60 B	19.47%
VRTX	29.73	6.31	21.22%	0.00%	$ 109.25 B	31.35%
MCK	26.63	-185.79	-697.75%	0.34%	$ 107.39 B	1.04%
ADMA	19.60	9.52	48.57%	0.00%	$ 4.11 B	42.87%
CAH	31.26	-18.26	-58.40%	0.97%	$ 49.86 B	0.68%
BIIB	16.02	1.42	8.83%	0.00%	$ 25.77 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CYCCP Historical Dividends

current DY: 33.29%

5-year average DY: 2,838.38%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	10/20/2025	11/01/2025	0,15000000
Dividend	07/21/2025	08/01/2025	0,15000000
Dividend	04/29/2025	05/01/2025	2,25000000
Dividend	01/22/2024	02/01/2024	2,25000000
Dividend	10/20/2023	11/01/2023	2,25000000
Dividend	07/21/2023	08/01/2023	2,25000000
Dividend	04/21/2023	05/01/2023	2,25000000
Dividend	01/13/2023	02/01/2023	2,25000000
Dividend	10/14/2022	11/01/2022	2,25000000
Dividend	07/15/2022	08/01/2022	2,25000000
Dividend	04/14/2022	05/01/2022	2,25000000
Dividend	01/14/2022	02/01/2022	2,25000000
Dividend	10/15/2021	11/01/2021	2,25000000
Dividend	07/16/2021	08/01/2021	2,25000000
Dividend	04/16/2021	05/01/2021	2,25000000
Dividend	01/15/2021	02/01/2021	2,25000000
Dividend	10/16/2020	11/01/2020	2,25000000
Dividend	07/17/2020	08/01/2020	2,25000000
Dividend	04/15/2020	05/01/2020	2,25000000
Dividend	01/17/2020	02/01/2020	2,25000000
Dividend	10/14/2019	11/01/2019	2,25000000
Dividend	07/12/2019	08/01/2019	2,25000000
Dividend	04/15/2019	05/01/2019	2,25000000
Dividend	01/14/2019	02/01/2019	2,25000000
Dividend	10/15/2018	11/01/2018	2,25000000
Dividend	07/13/2018	08/01/2018	2,25000000
Dividend	04/11/2018	05/01/2018	2,25000000
Dividend	01/12/2018	02/01/2018	2,25000000
Dividend	10/13/2017	11/01/2017	2,25000000
Dividend	07/14/2017	08/01/2017	2,25000000
Dividend	04/14/2017	05/01/2017	2,25000000
Dividend	01/18/2017	02/01/2017	2,25000000
Dividend	10/17/2016	11/01/2016	2,25000000
Dividend	07/15/2016	08/01/2016	2,25000000
Dividend	04/18/2016	05/01/2016	2,25000000
Dividend	01/21/2016	02/01/2016	2,25000000
Dividend	10/23/2015	11/02/2015	2,25000000
Dividend	07/17/2015	08/03/2015	2,25000000
Dividend	04/17/2015	05/01/2015	2,25000000
Dividend	01/05/2015	02/02/2015	2,25000000
Dividend	10/01/2014	11/01/2014	2,25000000
Dividend	07/01/2014	08/01/2014	2,25000000
Dividend	04/18/2014	05/01/2014	2,25000000
Dividend	01/17/2014	02/03/2014	2,25000000
Dividend	10/21/2013	11/01/2013	2,25000000
Dividend	07/22/2013	08/01/2013	2,25000000
Dividend	04/19/2013	05/01/2013	2,25000000
Dividend	01/22/2013	02/01/2013	2,25000000
Dividend	04/22/2011	05/02/2011	2,25000000
Dividend	01/21/2011	02/01/2011	2,25000000
Dividend	01/19/2009	01/30/2009	2,25000000
Dividend	10/20/2008	11/01/2008	2,25000000
Dividend	07/18/2008	08/01/2008	2,25000000
Dividend	04/18/2008	05/01/2008	2,25000000
Dividend	01/18/2008	02/01/2008	2,25000000
Dividend	10/19/2007	11/01/2007	2,25000000
Dividend	07/20/2007	08/01/2007	2,25000000
Dividend	04/20/2007	05/01/2007	2,25000000
Dividend	01/22/2007	02/01/2007	2,25000000
Dividend	10/23/2006	11/01/2006	2,25000000
Dividend	07/24/2006	08/01/2006	2,25000000
Dividend	04/29/2006	05/01/2006	2,25000000
Dividend	01/20/2006	02/01/2006	2,25000000
Dividend	10/21/2005	11/01/2005	2,25000000
Dividend	07/22/2005	08/01/2005	2,25000000
Dividend	04/22/2005	05/02/2005	2,25000000
Dividend	01/21/2005	02/01/2005	2,19600000

ABOUT THE COMPANY Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

Average user rating I10

4.0 (1 people)

United States

28 years

Founded: 1997

2006

Time since IPO - 19 years

12

Employees

The Company Cyclacel Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market cap of $ 11.39 Millions, having an equity of $ 3.63 Millions.

With a total of 12 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -1.32 Million.

As for its main indicators, the Company has a P/E ratio of -8.63, a P/BV ratio of 3.14 and in the last 12 months the dividend yield of CYCCP was at 33.29%.

The Company is traded internationally through the ticker CYCCP.

Market cap

$ 11.39 Millions

Equity

$ 3.63 Millions

US$ 3,630,000.00

Assets

$ 4.40 Millions

US$ 4,400,000.00

Total Shares Outstanding

1.58 Million

1,580,000

Average Daily Trading Volume

$ 7.47 Thousand

US$ 7,474.58

Sector

Health Care

Industry

Biotechnology

CYCCP

CYCCP revenue and profits

Financial Results CYCCP

DRAG THE FRAME TO SEE MORE DATA

CYCCP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 881.12 40,95% (12M)

P/E

26.63

0.34%

ROE

-697.75%

P/BV

-185.79

CAH - Cardinal Health

$ 212.26 76,57% (12M)

P/E

31.26

0.97%

ROE

-58.40%

P/BV

-18.26

JNJ - Johnson & Johnson

$ 206.92 38,72% (12M)

P/E

19.42

2.51%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 104.83 7,90% (12M)

P/E

12.83

3.31%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.74 6,90% (12M)

P/E

14.23

6.95%

ROE

10.56%

P/BV

1.50

ABBV - AbbVie

$ 227.70 28,82% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 92.72 40,04% (12M)

P/E

30.03

1.72%

ROE

20.45%

P/BV

6.14

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 881.12 40,95% (12 M)

P/L

26.63

0.34%

ROE

-697.75%

P/VP

-185.79

CAH - Cardinal Health

$ 212.26 76,57% (12 M)

P/L

31.26

0.97%

ROE

-58.40%

P/VP

-18.26

JNJ - Johnson & Johnson

$ 206.92 38,72% (12 M)

P/L

19.42

2.51%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 104.83 7,90% (12 M)

P/L

12.83

3.31%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.74 6,90% (12 M)

P/L

14.23

6.95%

ROE

10.56%

P/VP

1.50

ABBV - AbbVie

$ 227.70 28,82% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 92.72 40,04% (12 M)

P/L

30.03

1.72%

ROE

20.45%

P/VP

6.14

Frequently Asked Questions

What is the price of Cyclacel Pharmaceuticals (CYCCP) today?

The price of Cyclacel Pharmaceuticals (CYCCP) today is $ 0.00, with return of 0% compared to the last year. The price of Cyclacel Pharmaceuticals (CYCCP) started the year trading around $ 0.56 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Cyclacel Pharmaceuticals (CYCCP) and international markets.

When does Cyclacel Pharmaceuticals (CYCCP) pay dividends?

Cyclacel Pharmaceuticals (CYCCP) distributed dividends in the last year,in the months of May, August and November totaling $ 0.45. The Dividend Yield for the last 12 months is 33.29%.

Is Cyclacel Pharmaceuticals (CYCCP) worth it?

Currently, Cyclacel Pharmaceuticals (CYCCP) is priced at $ 0.00, with a P/E of -8.63%, representando um desvio de -863% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.45 in dividends, resulting in a Dividend Yield of 33.29%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Cyclacel Pharmaceuticals (CYCCP) stock?

Investing in stocks of Cyclacel Pharmaceuticals (CYCCP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Cyclacel Pharmaceuticals (CYCCP) yield today?

The yield of Cyclacel Pharmaceuticals (CYCCP) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.45 in dividends, a Dividend Yield of 33.29%.

If you wanted to buy 100 stocks of Cyclacel Pharmaceuticals (CYCCP) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CYCCP

Cyclacel Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of CYCCP

review the fundamentals of Cyclacel Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 33.29%

5-year average DY: 2,838.38%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

United States

28 years

2006

12

Financial Results CYCCP

CYCCP cash flow

asset growth - CYCCP

CYCCP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions